Valuation: PFIZER

Market Cap 143B 0 124B 116B 106B 200B 13,599B 204B 1,362B 534B 6,780B 536B 524B 22,454B P/E 2026 *
12.7x
P/E 2027 * 13.1x
Enterprise Value 192B 0 167B 156B 143B 270B 18,305B 274B 1,834B 719B 9,126B 721B 705B 30,224B EV / Sales 2026 *
3.11x
EV / Sales 2027 * 3.13x
Free-Float
59.05%
Yield 2026 *
6.88%
Yield 2027 * 6.94%
Manager TitleAgeSince
Chief Executive Officer 64 01/01/2019
Director of Finance/CFO 60 02/05/2022
Chief Tech/Sci/R&D Officer - 01/01/2007
Director TitleAgeSince
Director/Board Member 68 01/09/2007
Director/Board Member 62 27/09/2013
Chairman 64 01/01/2020
Change 5-day change 1-year change 3-year change Capi.($)
-2.39%-6.24%+47.10%+146.73% 1,024B
-0.76%-3.41%+52.04%+49.73% 618B
-2.33%-5.50%+25.55%+64.08% 443B
+0.68%+0.25%+38.47%+31.95% 349B
-1.66%-1.89%+32.18%+37.17% 297B
-8.96%-9.23%+3.57%+3.64% 264B
-1.37%-5.71%-2.10%-44.43% 209B
-1.63%+0.75%+27.62%+64.43% 208B
+0.72%+1.42%+15.88%+73.30% 162B
Average -1.27%-1.35%+26.70%+47.40% 397.08B
Weighted average by Cap. -0.88%-2.17%+34.56%+69.56%

Financials

2026 *2027 *
Net sales 61.74B 0 53.65B 50.03B 45.98B 86.71B 5,886B 88.23B 590B 231B 2,934B 232B 227B 9,718B 59.37B 0 51.59B 48.11B 44.21B 83.37B 5,659B 84.83B 567B 222B 2,821B 223B 218B 9,344B
Net income 10.63B 0 9.24B 8.62B 7.92B 14.93B 1,014B 15.19B 102B 39.79B 505B 39.93B 39.05B 1,674B 10.28B 0 8.93B 8.33B 7.66B 14.44B 980B 14.69B 98.18B 38.47B 489B 38.6B 37.76B 1,618B
Net Debt 49.36B 0 42.89B 40B 36.76B 69.32B 4,706B 70.54B 471B 185B 2,346B 185B 181B 7,770B 43.17B 0 37.51B 34.98B 32.14B 60.62B 4,115B 61.68B 412B 162B 2,051B 162B 159B 6,794B
Logo PFIZER
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (42.9%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (28%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (26.9%); - other (2.2%). The United States accounts for 59.2% of net sales.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
A